🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Insurance denied me AGAIN - I am so frustrated — 12 month update

Insurance denied me AGAIN - I am so frustrated — 12 month update

NeuroNate Tue, Jan 9, 2024 at 10:43 AM 9 replies 2,226 viewsPage 1 of 2
This thread is more than 29 months old. Information may be outdated. Consider searching for more recent discussions.
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Jan 9, 2024 at 10:43 AM#1

The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from the outside.

So the question, as narrowly as I can put it: what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work.

I have searched first, so if this is covered somewhere point me at it and I will read it.

12 7jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 9 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Jan 9, 2024 at 11:39 AM#2
NeuroNate said:
The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…
NeuroNate said:
...compounded vs brand cost and coverage...

This debate comes up weekly and I think both sides have valid points:

Pro-brand: FDA-approved, manufacturing standards guaranteed, clinical trial data directly applicable

Pro-compounded: 10x cost savings, same active molecule, independent testing available, accessibility

My position: if you can afford brand or have insurance coverage, that's the gold standard. If not, properly tested compounded from a 503B pharmacy is a reasonable alternative. Neither side should shame the other.

11 6ZaraB_AL, JakeSmashed95, NauseaFreeNow and 8 others
Reply Quote Save Share Report
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
Jan 9, 2024 at 12:35 PM#3
amsterdam_pete said:
NeuroNate said: ...compounded vs brand cost and coverage...
amsterdam_pete said:
...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

10 5dave_SLC, FDA_TrackerJim, ricardo_MIA and 7 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Jan 9, 2024 at 1:31 PM#4
NeuroNate said:
The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…

This matches mine closely enough to be worth saying so out loud. The detail I would add is minor and it is already implied above.

Last edited: Jan 9, 2024 at 7:31 PM
9 4SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 6 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Jan 9, 2024 at 6:52 PM#5

Clinical perspective, offered as context rather than as advice.

NeuroNate said:
...my insurance denied cost and coverage coverage because...

Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:

  1. Document medical necessity (BMI, comorbidities, failed alternatives)
  2. Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
  3. Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
  4. Request peer-to-peer review between your doctor and the plan's medical director
  5. File external appeal with your state insurance department if internal appeal fails

Don't accept the first denial. The appeal process exists for a reason.

Last edited: Jan 9, 2024 at 8:52 PM
8 3Dr.ObesityLA, NurseKim_ATL, paul_denver and 5 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register